Paul Y. Song, Chief Executive Officer at NKGen Biotech, Inc. (NKGN), bought 152 shares at $2.85 ($430) on 2023-11-22, disclosed to the SEC on 2023-11-22.
Open-market purchase of $430 NKGN by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.80 | 100 | $280 | 65.1% |
| 2 | $2.85 | 52 | $150 | 34.9% |
| Total | $2.83 avg | 152 | $430 | 100% |
| Filing → |
| NKGN | BUY | 2023-12-05 | $850 | — | Filing → |
| NKGN | BUY | 2023-11-28 | $701 | — | Filing → |